Learn more about how the FDA-approved Impella, the world's smallest heart pump, is safe, effective and supports your heart during a procedure. Hear the stories of patients and explore the latest innovations in Impella technology.

2024年10月14日 · Impella may be utilized to decompress the left ventricle in the context of VA-ECMO. The systolic LV pressure may continuously be lower than the aortic pressure due to the left ventricle's inability to contract.

Impella is a family of medical devices used for temporary ventricular support in patients with depressed heart function. Some versions of the device can provide left heart support during other forms of mechanical circulatory support including ECMO and Centrimag.

2022年4月26日 · Impella BTR, a forward flow heart pump that is implanted via the axillary artery and sits in the left ventricle, can pump greater than six liters of blood per minute. It is smaller and less invasive than current LVADs and allows patients with chronic heart failure to have a longer-term minimally invasive heart pump option.

The Impella CP with SmartAssist heart pump is designated as safe and effective by the FDA for use during high-risk PCI procedures and for patients in cardiogenic shock. It is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery.

Impella is an FDA-approved heart pump used to support the heart during a percutaneous revascularization procedure. An Impella heart pump-supported procedure is performed by an Interventional Cardiologist and could greatly improve heart failure and coronary artery disease (CAD) patients’ outcomes—including patients who were turned down for ...

Impella is the only U.S. FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI

2017年12月16日 · Impella® is a percutaneous axial heart pump placed retrograde across the aortic valve into the left ventricle (LV) utilizing fluoroscopy +/- echocardiography. Its indications include high-risk percutaneous coronary intervention (PCI, especially cardiogenic shock or signs of ongoing ischemia), post-cardiotomy failure, and myocarditis.

2022年8月15日 · The Impella heart pump is a small pump that a healthcare professional can insert without surgery. It can help maintain blood flow in people who have CAD, are recovering from cardiogenic...

Impella heart pumps have the unique ability to enable heart recovery, allowing patients to return home with their native hearts. Impella is the only non-surgical heart pump that is FDA-approved as safe and effective for high-risk patients receiving a percutaneous coronary intervention (PCI).